{"product_id":"steris-five-forces-analysis","title":"Steris Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eSteris faces moderate supplier power and high buyer scrutiny amid intense competition and regulatory scrutiny, while barriers to entry remain substantial due to specialized tech and certifications; however, substitutes and consolidation risks warrant close monitoring. This snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Steris’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Material Dependency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTERIS depends on high-grade stainless steel, specialized polymers and precision electronics; in 2024 about 62% of its COGS for devices tied to these inputs, so supplier disruptions can delay production and revenue recognition.\u003c\/p\u003e\n\u003cp\u003eIts global supplier network reduces single-source risk, but strict healthcare-grade specs shrink qualified vendors—an estimated 8–12 firms per component class—raising switching costs and lead times.\u003c\/p\u003e\n\u003cp\u003eIn 2025 STERIS reported supplier-related inventory spikes worth $85M, showing material bottlenecks can elevate working capital and compress margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy and Utility Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Applied Sterilization Technologies segment is energy-heavy—Gamma and E-beam plants consume large power loads—so 2024 energy price swings (U.S. industrial electricity up ~7% year-over-year through Q3 2024) directly raised STERIS service costs and compressed margins.\u003c\/p\u003e\n\u003cp\u003eLocal utility rules and capacity constraints tie plants to specific grids, limiting quick supplier swaps; estimated energy can be 10–20% of per-procedure cost in radiative sterilization, raising supplier bargaining power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance of Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers to STERIS must meet FDA and EMA quality rules, raising entry barriers and boosting power of certified vendors; about 70% of medical-device suppliers face ISO 13485 certification demands as of 2025. This concentrated, compliant supply base increases vendor leverage and forces STERIS to run strict audits and traceability—company reports show supplier quality events under 0.5% but any failure could risk product recalls and multimillion-dollar liabilities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Labor Market Constraints\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe operation and maintenance of STERIS’s complex sterilization systems require highly skilled technicians and engineers with niche expertise, and rising global healthcare tech deployment pushed demand: global medical device service market grew ~6.2% CAGR to $30.4B in 2024, tightening labor supply.\u003c\/p\u003e\n\u003cp\u003eAs competition for this workforce rises, technicians gain bargaining leverage; STERIS reported $220M in selling, general \u0026amp; administrative R\u0026amp;D-related training and service investment in FY2024 to reduce turnover and avoid service disruptions.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eHighly specialized skills raise supplier (labor) leverage\u003c\/li\u003e\n\u003cli\u003eMedical device service market ~$30.4B in 2024, 6.2% CAGR\u003c\/li\u003e\n\u003cli\u003eSTERIS invested ~$220M in training\/retention FY2024\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Niche Components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eConcentration of niche components like proprietary filters and Cobalt-60 isotopes—sourced from fewer than 5 global suppliers—gives vendors strong pricing and delivery leverage, occasionally causing 5–10% cost spikes in 2024 supply disruptions.\u003c\/p\u003e\n\u003cp\u003eSTERIS mitigates this via multi-year contracts covering ~60% of critical inputs and strategic inventory holding equal to 3–6 months of usage for critical care and AST lines.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFew suppliers: \u0026lt;5 global sources\u003c\/li\u003e\n\u003cli\u003eCost impact: 5–10% spike in 2024\u003c\/li\u003e\n\u003cli\u003eContracts: ~60% inputs under multi-year deals\u003c\/li\u003e\n\u003cli\u003eInventory: 3–6 months buffer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier squeeze: \u0026lt;5 vendors, 60% contracted, 5–10% cost spikes, $85M inventory hit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong leverage: critical inputs often come from \u0026lt;5 global vendors, 60% of inputs under multi-year contracts, 3–6 months safety stock; 2024 disruptions caused 5–10% cost spikes and $85M inventory build; certified vendors (ISO 13485) limit switches—≈70% industry compliance in 2025—and energy costs (U.S. industrial electricity +7% y\/y through Q3 2024) further raise supplier bargaining power.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCritical suppliers\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContracted inputs\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSafety stock\u003c\/td\u003e\n\u003ctd\u003e3–6 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 cost spikes\u003c\/td\u003e\n\u003ctd\u003e5–10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory impact\u003c\/td\u003e\n\u003ctd\u003e$85M (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISO 13485 prevalence\u003c\/td\u003e\n\u003ctd\u003e~70% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. industrial electricity\u003c\/td\u003e\n\u003ctd\u003e+7% y\/y (through Q3 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Steris, this Porter's Five Forces analysis uncovers key drivers of competition, supplier and buyer power, entry barriers, substitutes, and disruptive threats, evaluating how each force influences Steris’s pricing, profitability, and market position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Steris Porter's Five Forces one-sheet that visualizes competitive pressures and supplier\/customer leverage for fast strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGroup Purchasing Organization Influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa significant portion of steris healthcare revenue in from contracts with large group purchasing organizations and integrated delivery networks which use collective buying power to force lower prices stricter terms for example gpo-negotiated discounts can reach on consumables. consolidation among the top u.s. gpos control hospital continues squeeze equipment consumable margins pressuring gross margin that fell\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Switching Costs for Integrated Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOnce a hospital or pharma lab integrates STERIS equipment into workflows, switching costs are prohibitively high: in 2024 average capital spend per sterile-processing suite was about $1.2M, plus software integration and validated procedures that can take 6–12 months.\u003c\/p\u003e\n\u003cp\u003eIntegration covers hardware, proprietary software, staff training and validation, and multi-year service contracts—STERIS reports service revenue grew 9% in 2024, reflecting sticky installed bases.\u003c\/p\u003e\n\u003cp\u003eThis technological lock-in cuts individual customer bargaining power after initial investment, since replacing systems risks months of downtime, regulatory revalidation, and millions in incremental cost.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMission-Critical Nature of Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe products and services STERIS provides are mission-critical for surgical suites and sterile processing; industry data show hospitals lose about $1,500–$2,000 per OR minute of downtime, so uptime and rapid service matter more than price. Because equipment failures can cancel procedures and cut revenue, customers prioritize reliability and fast on-site service, letting STERIS capture pricing power even versus large hospital systems. In 2024 STERIS reported service revenue of $1.6 billion, underscoring this dependency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Hospital Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe consolidation of US hospital systems—61% of hospitals in 2024 belonged to multihospital systems per AHA—creates large, professional buyers with centralized procurement and advanced analytics, raising STERIS’s customer bargaining power.\u003c\/p\u003e\n\u003cp\u003eThese systems demand transparent pricing across regions and rigorous cost-benefit proof; STERIS must link premium pricing to measurable patient-safety gains and clinical-outcome improvements to win contracts.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e61% of US hospitals in systems (AHA, 2024)\u003c\/li\u003e\n\u003cli\u003eCentralized procurement increases negotiation leverage\u003c\/li\u003e\n\u003cli\u003eDemand for regional price transparency\u003c\/li\u003e\n\u003cli\u003eNeed data tying STERIS premium to safety\/outcomes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Compliance Pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCustomers face strict zero-tolerance rules from health authorities on healthcare-associated infections, driving demand for STERIS’s validation and sterilization services—FDA and CDC guidance raised enforcement actions by ~12% in 2024, so compliance lapses carry major legal and reputational risk.\u003c\/p\u003e\n\u003cp\u003eAs a result, buyers prioritize proven partners: STERIS reported 2024 revenues of $4.9B and growth in validation services, showing customers often accept premium pricing to avoid noncompliance.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eZero-tolerance regulatory pressure\u003c\/li\u003e\n\u003cli\u003eEnforcement actions +12% in 2024\u003c\/li\u003e\n\u003cli\u003eSTERIS 2024 revenue $4.9B\u003c\/li\u003e\n\u003cli\u003eCompliance risk \u0026gt; price in procurement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSTERIS: Pricing Pressure from GPOs vs. High Switching Costs and $4.9B Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomers wield strong price leverage via GPOs\/IDNs (top 5 GPOs ≈70% hospital purchasing) forcing 20–30% discounts, yet high switching costs (≈$1.2M per sterile suite, 6–12 months validation) and mission-critical uptime (loss ≈$1,500–$2,000\/OR minute) give STERIS countervailing pricing power; 2024: revenue $4.9B, service rev $1.6B, gross margin 36.8%, hospital systems 61% (AHA).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$4.9B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService rev\u003c\/td\u003e\n\u003ctd\u003e$1.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e36.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital systems\u003c\/td\u003e\n\u003ctd\u003e61%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eSteris Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Steris Porter’s Five Forces analysis you'll receive immediately after purchase—no surprises, no placeholders. It presents the full competitive landscape assessment, including bargaining power of suppliers and customers, threat of new entrants and substitutes, and industry rivalry. The document is professionally formatted and ready for download the moment you buy. You’re viewing the final deliverable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747470487929,"sku":"steris-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/steris-five-forces-analysis.png?v=1772198912","url":"https:\/\/matrixbcg.com\/products\/steris-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}